Journal articleClinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association · July 2026
Background & aimsAcute liver failure (ALF) due to idiosyncratic drug-induced liver injury (DILI) has a poor prognosis. We set out to identify presenting features associated with nonspontaneous survival in hospitalized patients with severe idiosync ...
Full textCite
Journal articleDrug Saf · February 2025
BACKGROUND: The attribution of drug-induced liver injury (DILI) to specific herbal and dietary supplements (HDS) is confounded by inaccurate labels and undisclosed ingredients. The US Drug-Induced Liver Injury Network (DILIN) determines the attribution of ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · June 30, 2020
BACKGROUND: The CABANA (Catheter Ablation Versus Antiarrhythmic Drug Therapy for Atrial Fibrillation) trial randomized 2,204 patients with atrial fibrillation (AF) to catheter ablation or drug therapy. Analysis by intention-to-treat showed a nonsignificant ...
Full textOpen AccessLink to itemCite
Journal articleGastroenterology · June 2015
BACKGROUND & AIMS: The Drug-Induced Liver Injury Network is conducting a prospective study of patients with DILI in the United States. We present characteristics and subgroup analyses from the first 1257 patients enrolled in the study. METHODS: In an obser ...
Full textLink to itemCite